<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-105819" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Initial Antepartum Care</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Karrar</surname>
            <given-names>Shahd A.</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vadakekut</surname>
            <given-names>Elsa S.</given-names>
          </name>
          <aff>American College of Osteopathic Obstetricians and Gynecologists</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hong</surname>
            <given-names>Peter L.</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shahd Karrar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Elsa Vadakekut declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Peter Hong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-105819.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Antepartum care is the health care provided during pregnancy to optimize outcomes for both the mother and the fetus. The&#x000a0;primary objective of the initial antenatal care visit is to establish the estimated delivery date, identify high-risk pregnancies, and perform maternal and fetal screening.&#x000a0;During the initial visit, which ideally occurs in the first trimester, prenatal care assessments involve taking a complete medical history, performing physical and gynecological exams, and conducting laboratory and imaging studies. High-risk pregnancies necessitate more frequent surveillance. In addition to initial medical history, the first antepartum visit involves complex clinical assessments, including potential exposures to infections or toxins, and psychosocial assessments to identify issues such as mental health concerns, barriers to care, and exposure to violence and monitoring for potential complications, including baseline metrics (eg, blood pressure, weight, and height), fetal heart activity, and screens for conditions (eg, anemia, infections, and sexually transmitted diseases).&#x000a0;This activity for healthcare professionals reviews recommended prenatal screening,&#x000a0;fetal surveillance, and patient education,&#x000a0;ensuring early identification of high-risk pregnancies, timely antepartum interventions, and improved maternal and fetal outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the components of the initial antepartum care visit.</p></list-item><list-item><p>Implement recommended screening tests during the initial antepartum visit.</p></list-item><list-item><p>Differentiate low-risk pregnancies from high-risk pregnancies.</p></list-item><list-item><p>Apply interprofessional team strategies to improve antepartum care coordination and patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=105819&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=105819">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-105819.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Antepartum care, or prenatal care, is the health care provided during pregnancy to optimize outcomes for both the mother and the fetus. The&#x000a0;primary objective of the initial antenatal care visit is to establish the estimated delivery date, identify high-risk pregnancies, and perform maternal and fetal screening. During the initial visit, which ideally occurs in the first trimester, prenatal care assessments involve taking a complete medical history, performing physical and gynecological exams, and conducting laboratory and imaging studies. High-risk pregnancies necessitate more frequent surveillance.&#x000a0;</p>
        <p>Prenatal care has become the most frequently utilized healthcare service within the United States (US), with 98% of women who give birth initiating regular care at some point in their pregnancy.<xref ref-type="bibr" rid="article-105819.r1">[1]</xref>&#x000a0;After the first positive pregnancy test, care is typically sought by patients and begins after a confirmed sonographic intrauterine pregnancy.&#x000a0;In addition to initial medical history, the first antepartum visit involves complex clinical assessments, including potential exposures to infections or toxins, and psychosocial assessments to identify issues such as mental health concerns, barriers to care, and exposure to violence and monitoring for potential complications, including maternal metrics (eg, blood pressure, weight, and height), fetal heart activity, and screens for maternal-fetal conditions (eg, anemia, infections, and sexually transmitted diseases).<xref ref-type="bibr" rid="article-105819.r2">[2]</xref><xref ref-type="bibr" rid="article-105819.r3">[3]</xref><xref ref-type="bibr" rid="article-105819.r4">[4]</xref></p>
        <p>Ultrasound examinations are essential for accurate gestational dating, detecting multiple pregnancies, and screening for congenital anomalies. Prenatal genetic screening for conditions like aneuploidies and carrier screenings for genetic disorders are also offered.&#x000a0;Laboratory tests during prenatal visits confirm pregnancy and screen for conditions such as anemia, infections, and sexually transmitted diseases. Based on individual risk factors, targeted screenings for thyroid function, diabetes, and other conditions are performed. With the increasing focus beginning in the early 1990s on preventing maternal and fetal morbidity and mortality, great efforts have been made to improve access to quality antepartum care for low socioeconomic and minority populations. Although still prevalent despite efforts, the growing disparities between minority populations are rooted in lack of access and complex obstetric and medical risk factors leading to poor obstetric outcomes. Consequently, this approach to antepartum care ensures early identification of potential complications, enabling timely interventions, improved maternal and fetal outcomes, and an enhanced antepartum experience for the patient.<xref ref-type="bibr" rid="article-105819.r2">[2]</xref><xref ref-type="bibr" rid="article-105819.r3">[3]</xref><xref ref-type="bibr" rid="article-105819.r4">[4]</xref></p>
      </sec>
      <sec id="article-105819.s3" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Initial Prenatal Visit</bold>
</p>
        <p>Ideally, a patient will initiate antepartum care in the first trimester as recommended&#x000a0;to facilitate early identification of high-risk pregnancies and genetic screening if elected. However, a great number of women only begin receiving antepartum care after the first trimester for several reasons, including social and health barriers.<xref ref-type="bibr" rid="article-105819.r5">[5]</xref><xref ref-type="bibr" rid="article-105819.r6">[6]</xref>&#x000a0;Several elements are involved in the initial antepartum visit, including establishing the baseline maternal-fetal medical condition, proper gestational age and dating, and shared decision-making concerning the intended course of obstetric care. Components of the initial prenatal visit should include a complete medical history, physical exam, pregnancy confirmation, initial prenatal screening tests, genetic screening or diagnostic studies, and anticipatory counseling. Additionally, an obstetrical ultrasound crown-rump length (CRL) assessment at &#x02264;14 weeks gestation is beneficial in accurately calculating fetal gestational age and is recommended if a patient's last menstrual period is unreliable or unknown.<xref ref-type="bibr" rid="article-105819.r7">[7]</xref><xref ref-type="bibr" rid="article-105819.r8">[8]</xref>&#x000a0;Most facilities use an electronic or paper obstetrical record to document a summary of these components from each antepartum visit together for easier review.</p>
        <p><bold>Clinical history</bold>&#x000a0;</p>
        <p>Obtaining a complete medical history is critical to identify potential pregnancy complications and help determine the optimal management approach for individual patients.<xref ref-type="bibr" rid="article-105819.r9">[9]</xref> The following should be obtained as part of the clinical history:</p>
        <list list-type="bullet">
          <list-item>
            <p>Medical history, including demographic information (eg, occupation, race and ethnicity, marital status), religious or other restrictions (eg, receiving blood products and dietary restrictions), medications, and immunizations</p>
          </list-item>
          <list-item>
            <p>Obstetrical and gynecologic history, including if the current pregnancy was intended, menstrual regularity, and last menstrual period</p>
          </list-item>
          <list-item>
            <p>Family history, including genetic conditions and disorders in multiple family members</p>
          </list-item>
          <list-item>
            <p>Surgical history</p>
          </list-item>
          <list-item>
            <p>Social history, including recent travel, tobacco use, alcohol and drug use, and histories of sexual trauma or intimate partner violence</p>
          </list-item>
          <list-item>
            <p>Psychosocial assessments using established screening tools for intimate partner violence (eg, HARK or HITS) <xref ref-type="bibr" rid="article-105819.r10">[10]</xref>, substance abuse, depression (eg, Edinburgh Postnatal Depression Scale), and social determinants of health (eg,&#x000a0;PRAPARE or THRIVE)&#x000a0;<xref ref-type="bibr" rid="article-105819.r11">[11]</xref><xref ref-type="bibr" rid="article-105819.r12">[12]</xref>&#x000a0;See StatPearls' companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/27543">Postpartum Depression</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/40654">Domestic Violence</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/36546">Substance Use in Pregnancy</ext-link>," for more information on these screening tests.</p>
          </list-item>
        </list>
        <p>
<bold>Physical examination</bold>
</p>
        <p>A complete physical examination should also be performed, including complete vital signs, maternal weight, pelvic examination, fundal height, and, depending on the gestational age at presentation, fetal heart rate.<xref ref-type="bibr" rid="article-105819.r9">[9]</xref> The US Preventive Services Task Force (USPSTF) recommends obtaining a baseline blood pressure at the initial visit with reevaluation at each prenatal visit, as this is essential to identify hypertensive disorders in pregnancy. Furthermore, preexisting hypertensive disorders (eg, chronic hypertension) may only be discovered during a prenatal evaluation as the antepartum visit may be the only encounter a young female has had with a health professional. An appropriately sized sphygmomanometer should be used with a larger size cuff in patients with an arm circumference &#x0003e;33 cm. Obtaining an accurate blood pressure measurement is critical. Therefore, clinicians should ensure that patients are relaxed and in a seated position with back support and legs uncrossed while their blood pressure is measured with their arm at the level of the right atrium.<xref ref-type="bibr" rid="article-105819.r13">[13]</xref>&#x000a0;A positive screening result for hypertension during pregnancy is a systolic blood pressure of &#x02265;140 mm Hg or diastolic blood pressure of &#x02265;90 mm Hg&#x000a0;measured twice at least 4 hours apart in a patient without chronic hypertension.<xref ref-type="bibr" rid="article-105819.r14">[14]</xref>&#x000a0;</p>
        <p>Furthermore, maternal body mass index (BMI) should be calculated at the initial prenatal visit as a BMI of&#x000a0;&#x02265;30 kg/m<sup>2</sup>&#x000a0;is associated with a higher risk of several pregnancy complications, including fetal death,&#x000a0;preeclampsia, gestational diabetes, and preterm birth than patients with a normal BMI.<xref ref-type="bibr" rid="article-105819.r15">[15]</xref>&#x000a0;During the pelvic examination, uterine size should be assessed to correlate with the estimated gestational age calculated by the last menstrual period; if an&#x000a0;incongruity is noted, further evaluation with ultrasound is indicated.<xref ref-type="bibr" rid="article-105819.r9">[9]</xref></p>
        <p>
<bold>Pregnancy confirmation</bold>
</p>
        <p>Many women of reproductive age will present for evaluation of various complaints for which pregnancy is the differential diagnosis that should be excluded first, including amenorrhea, abdominal pain, and irregular menses. If pregnancy has not been confirmed by ultrasound imaging before the first visit, a urine or serum beta-human chorionic gonadotropin (&#x003b2;-hCG) should be performed. This hormone comprises dissimilar alpha and beta subunits required for biological activity.&#x000a0;&#x003b2;-hCG levels between the serum and urine specimens correlate&#x000a0;well but&#x000a0;depend on urine-specific gravity. Ideally, a first void is preferred for urine specimens due to increased concentration.<xref ref-type="bibr" rid="article-105819.r16">[16]</xref>&#x000a0;However,&#x000a0;an elevated &#x003b2;-hCG level is not definitive of a normal or viable pregnancy. Differential diagnoses that may result in elevated &#x003b2;-hCG levels must be considered, including ectopic and heterotopic pregnancy, miscarriage, and gestational trophoblastic disease. Confirmation of a viable intrauterine pregnancy requires ultrasound imaging. Typically, a normal intrauterine pregnancy is visible on transvaginal ultrasound at approximately 5 to 6 weeks gestation. However, in patients with an unknown or unreliable last menstrual period (LMP) or indications for an early ultrasound (eg, vaginal bleeding and pelvic pain), a quantitative serum&#x000a0;&#x003b2;-hCG can be&#x000a0;used to interpret ultrasound findings. The "discriminatory zone" refers to the quantitative &#x003b2;-hCG value at which a gestational sac should be seen within the endometrial cavity by transvaginal ultrasonography for an intrauterine pregnancy. The parameters for discriminatory zones vary depending on several factors; therefore, its use is debated, but the American College of Obstetricians and Gynecologists (ACOG) generally suggests using a high &#x003b2;-hCG threshold of approximately 3500&#x000a0;mIU/mL to prevent misdiagnosis of a viable intrauterine gestation. Furthermore, in patients with a serum quantitative &#x003b2;-hCG level under&#x000a0;the discriminatory zone or clinical features of an abnormal pregnancy, a repeat &#x003b2;-hCG may be performed; an approximate doubling of &#x003b2;-hCG levels in 48 hours is reassuring of a viable pregnancy in the early first trimester. Usually, the&#x000a0;&#x003b2;-hCG level will continue to increase in this fashion until 10 weeks gestation, plateauing at approximately 100,000&#x000a0;mIU/mL.<xref ref-type="bibr" rid="article-105819.r17">[17]</xref></p>
        <p>
<bold>Initial prenatal laboratory studies</bold>
</p>
        <p>ACOG recommends performing a standardized prenatal laboratory panel on every new obstetrical patient at the first visit, including complete blood count (CBC), ABO and RhD type, antibody screen, rubella serology, syphilis serology,&#x000a0;hepatitis B serology, and HIV serology (see <bold>Table.</bold>&#x000a0;Recommended Initial Prenatal Serum Laboratory Studies).<xref ref-type="bibr" rid="article-105819.r9">[9]</xref>&#x000a0;ACOG and the USPSTF recommend clinicians screen for asymptomatic bacteria with a urine culture to prevent pyelonephritis; USPSTF recommends performing the urine culture&#x000a0;at 12 to 16 weeks gestation or at the first prenatal visit, while ACOG only states it should be done at an early visit. However, collecting these laboratory studies simultaneously during the initial prenatal visit is typically easier for the clinician and the patient.<xref ref-type="bibr" rid="article-105819.r18">[18]</xref><xref ref-type="bibr" rid="article-105819.r19">[19]</xref>&#x000a0;</p>
        <p>ACOG also recommends targeted evaluation for some conditions in patients with risk factors, including diabetes and thyroid disease, because universal screening for these conditions has not been shown in studies to be as beneficial as those included in standardized prenatal testing. Early testing for type 2 diabetes with a 75-g or 50-g oral glucose tolerance test is recommended by ACOG at the initial prenatal visit in patients who have a BMI of &#x02265;30 kg/m<sup>2</sup>&#x000a0;and 1 of the following risk factors:</p>
        <list list-type="bullet">
          <list-item>
            <p>History of gestational diabetes mellitus&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hemoglobin A1C &#x02265;5.7% on previous testing</p>
          </list-item>
          <list-item>
            <p>Immediate family member with diabetes</p>
          </list-item>
          <list-item>
            <p>High-risk race (eg, African American, Latin American, Native American, Asian American, Pacific Islander)</p>
          </list-item>
          <list-item>
            <p>Cardiovascular disease history</p>
          </list-item>
          <list-item>
            <p>Hypertension&#x000a0;</p>
          </list-item>
          <list-item>
            <p>High-density lipoprotein (HDL) cholesterol level &#x0003c;35 mg/dL or a triglyceride level &#x0003e;250 mg/dL</p>
          </list-item>
          <list-item>
            <p>Polycystic ovary syndrome</p>
          </list-item>
          <list-item>
            <p>Physical inactivity&#x000a0;<xref ref-type="bibr" rid="article-105819.r20">[20]</xref></p>
          </list-item>
        </list>
        <p>However, recent studies have shown that early screening for gestational diabetes does not prevent adverse outcomes and may even lead to worse outcomes in select patients. Therefore, the effectiveness of the early gestational diabetes screening recommendation is debatable and requires additional studies.<xref ref-type="bibr" rid="article-105819.r21">[21]</xref><xref ref-type="bibr" rid="article-105819.r22">[22]</xref> Additionally, ACOG recommends targeted testing for thyroid disease in patients with the following risk factors:</p>
        <list list-type="bullet">
          <list-item>
            <p>Residing in an area of moderate to severe iodine insufficiency</p>
          </list-item>
          <list-item>
            <p>Hypothyroidism symptoms</p>
          </list-item>
          <list-item>
            <p>Family of thyroid disease</p>
          </list-item>
          <list-item>
            <p>History of:
<list list-type="bullet"><list-item><p>Thyroid peroxidase (TPO) antibodies</p></list-item><list-item><p>Goiter</p></list-item><list-item><p>Age &#x0003e;30 years</p></list-item><list-item><p>Type 1 diabetes</p></list-item><list-item><p>Head and neck radiation</p></list-item><list-item><p>Recurrent miscarriage or preterm delivery</p></list-item><list-item><p>Two or more previous pregnancies</p></list-item><list-item><p>BMI &#x02265;40 kg/m<sup>2</sup></p></list-item><list-item><p>Infertility</p></list-item><list-item><p>Thyroid surgery or disease</p></list-item><list-item><p>Recent administration of iodinated radiologic contrast agents, amiodarone, or lithium&#x000a0;<xref ref-type="bibr" rid="article-105819.r23">[23]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/36235">Thyroid Disease and Pregnancy</ext-link>," for more information on the evaluation and management of thyroid disease during pregnancy. Targeted screening assessment should also be considered for patients with clinical risks of infection, including Zika virus, cytomegalovirus, and tuberculosis.<xref ref-type="bibr" rid="article-105819.r24">[24]</xref><xref ref-type="bibr" rid="article-105819.r25">[25]</xref>&#x000a0;Furthermore, a Papanicolaou&#x000a0;test, as recommended per current guidelines, and gonorrhea and chlamydia cultures should be obtained during the pelvic examination at the initial visit. Any abnormal results found on antepartum testing should be followed up promptly so as to begin necessary adjustments to prenatal care, repeat laboratory testing, or initiate appropriate referrals.<xref ref-type="bibr" rid="article-105819.r9">[9]</xref>&#x000a0;Clinicians should also offer all pregnant patients prenatal screening and diagnostic testing for genetic disorders at the first visit. Thorough counseling on available genetic screening and diagnostic testing options (eg, cell-free DNA, serum-integrated screening, nuchal translucency screening, and chorionic villus sampling) depending on gestational age is critical to ensure patients are able to make informed decisions regarding the pregnancy.<xref ref-type="bibr" rid="article-105819.r26">[26]</xref><xref ref-type="bibr" rid="article-105819.r27">[27]</xref>&#x000a0;See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22182">Prenatal Genetic Screening</ext-link>," for more information. Depending on the patient's vaccination history, routine vaccinations considered safe during pregnancy, including COVID-19 and inactivated influenza, should be offered also.<xref ref-type="bibr" rid="article-105819.r28">[28]</xref><xref ref-type="bibr" rid="article-105819.r29">[29]</xref>&#x000a0;See StatPearls' companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/142084">Prevention, Evaluation, and Management of Coronavirus (COVID-19) in Pregnancy and Puerperium</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/23513">Influenza Vaccine</ext-link>," for more detailed information on these vaccines.</p>
        <table-wrap id="article-105819.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Recommended Initial Prenatal Serum Laboratory Studies</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">
<bold>Prenatal Test</bold>
</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<bold>Purpose</bold>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<bold>Recommended Management</bold>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">ABO Type</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>&#x000a0;Determination of maternal blood type&#x000a0;<xref ref-type="bibr" rid="article-105819.r9">[9]</xref></p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Following delivery, neonates with ABO incompatibility frequently develop hyperbilirubinemia;&#x000a0;See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/23157">Unconjugated Hyperbilirubinemia</ext-link>," for more information.</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">Antibody Screen</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Early identification of maternal alloimmunization, particularly&#x000a0;RhD-type&#x000a0;<xref ref-type="bibr" rid="article-105819.r30">[30]</xref></p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Clinicians should administer prophylactic anti(D)-immune globulin to RhD-negative patients without antibodies identified at 28 weeks gestation weeks in some countries) and when clinically indicated to prevent alloimmunization.</p></list-item><list-item><p>For patients with a positive antibody screen, further evaluation (eg, antibody identification and titers) should be performed.&#x000a0;See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22739">Hemolytic Disease of the Fetus and Newborn</ext-link>," for more information.<xref ref-type="bibr" rid="article-105819.r30">[30]</xref></p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">CBC</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>In the first and third trimesters, a hemoglobin level of &#x0003c;11 g/dL or in the second trimester &#x0003c;10.5 g/dL indicates anemia during pregnancy.<xref ref-type="bibr" rid="article-105819.r31">[31]</xref></p></list-item><list-item><p>A&#x000a0;mean corpuscular volume of&#x000a0;&#x0003c;80 fL may indicate anemia due to etiologies, including iron deficiency, anemia of chronic disease, or thalassemia. Conditions including folate and vitamin B12 deficiency or alcohol abuse are suggested by a mean corpuscular volume &#x0003e;100&#x000a0;fL.<xref ref-type="bibr" rid="article-105819.r31">[31]</xref></p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Empiric iron supplementation may be given for 7 to 10 days in patients without clinical indications of another etiology before further laboratory studies are performed.</p></list-item><list-item><p>Further laboratory testing, including serum ferritin, vitamin B12, folate, and hemoglobin electrophoresis, should be performed to determine the underlying etiology.</p></list-item><list-item><p>Supplementation should be prescribed if a deficiency is identified.<xref ref-type="bibr" rid="article-105819.r31">[31]</xref></p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">Rubella</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Determines rubella&#x000a0;immunity defined by the US Centers for Disease Control and Prevention (CDC) as a rubella immunoglobulin G concentration of &#x0003e;10 IU/mL.</p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>In pregnant patients with evidence of immunity, the measles&#x02013;mumps&#x02013;rubella (MMR) vaccine is contraindicated; the MMR vaccine should be administered postpartum.<xref ref-type="bibr" rid="article-105819.r9">[9]</xref>&#x000a0;See StatPearls' companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/102378">TORCH Complex</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/28670">Rubella Vaccine</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/19868">Congenital Rubella</ext-link>," for more information.&#x000a0;</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">Urine Culture</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Utilized to identify asymptomatic&#x000a0;bacteriuria&#x000a0;</p></list-item><list-item><p>Colony counts of &#x02265;100,000 CFU/mL are diagnostic of bacteriuria.<xref ref-type="bibr" rid="article-105819.r18">[18]</xref></p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Treat with targeted antibiotics for 5 to 7 days. The necessity for a repeated culture following treatment is unsupported.&#x000a0;</p></list-item><list-item><p>For group B streptococcus with &#x0003c;100,000 CFU/mL colony counts, treatment is not required; however, group B streptococcus prophylaxis at delivery is indicated.<xref ref-type="bibr" rid="article-105819.r18">[18]</xref>&#x000a0;See StatPearls' companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/30856">Urinary Tract Infection in Pregnancy</ext-link>"&#x000a0;and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22444">Group B&#x000a0;Streptococcus in Pregnancy</ext-link>," for more information.&#x000a0;</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">Syphilis</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Universal screening for syphilis infection with Venereal Disease Research Laboratory (VDRL) test or rapid plasma reagin (RPR) test is recommended by ACOG at the initial prenatal visit, the third trimester, and at delivery.<xref ref-type="bibr" rid="article-105819.r32">[32]</xref></p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Parenteral benzathine penicillin G is the recommended treatment for active syphilis infection during pregnancy. Desensitization protocol should be performed in patients with a severe penicillin allergy.<xref ref-type="bibr" rid="article-105819.r32">[32]</xref>&#x000a0;See StatPearls' companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/161219">Adverse Drug Reactions</ext-link>"&#x000a0;and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/19869">Congenital and Maternal Syphilis</ext-link>," for more information.</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">HIV</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>The USPSTF recommends HIV&#x000a0;screening in all pregnant persons, including patients presenting in labor with an unknown HIV status with&#x000a0;antigen/antibody immunoassay.<xref ref-type="bibr" rid="article-105819.r33">[33]</xref></p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Further testing with HIV-1 nucleic acid test should be performed in patients with abnormal or equivocal results on initial testing.<xref ref-type="bibr" rid="article-105819.r33">[33]</xref>&#x000a0;See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22931">HIV in Pregnancy</ext-link>," for more information.</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">Hepatitis B</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Screening for infection with hepatitis B surface antigen (HBsAg) is recommended by&#x000a0;USPSTF in all pregnant patients.<xref ref-type="bibr" rid="article-105819.r34">[34]</xref></p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">&#x000a0;
<list list-type="bullet"><list-item><p>If positive, further testing to determine active infection, resolving infection, chronic infection, immunity, or false-positive testing with antibodies to HBsAg (anti-HBs), total hepatitis B core antigen (anti-HBc), hepatitis B virus DNA, and IgM anti-HBc.<xref ref-type="bibr" rid="article-105819.r34">[34]</xref>&#x000a0;See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/91623">Pregnancy and Viral Hepatitis</ext-link>," for more information.</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 106.141px;" rowspan="1" colspan="1">Varicella</td>
                <td style="width: 408.859px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>According to the CDC, serology may be used to confirm immunity in patients without a clinical history of varicella infection or vaccination.</p></list-item></list>
</td>
                <td style="width: 373px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>In patients without evidence of immunity, varicella vaccination may be administered postpartum.<xref ref-type="bibr" rid="article-105819.r9">[9]</xref>&#x000a0;See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/130914">Congenital Varicella Syndrome</ext-link>," for more information.</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p><bold>Estimated due date</bold>&#x000a0;<bold>determination and first-trimester ultrasound</bold></p>
        <p>Determining an accurate estimated due date (EDD) is a critical component of antepartum care, as most obstetric management varies in relation to a patient's gestational age. According to ACOG, the American Institute of Ultrasound in Medicine, and the Society for Maternal-Fetal Medicine, a first-trimester ultrasound measurement (ie, no more than 13 6/7 weeks gestation) of the fetus is the most accurate modality to confirm an intrauterine pregnancy and determine the estimated gestational age (EGA).<xref ref-type="bibr" rid="article-105819.r35">[35]</xref>&#x000a0;The fetal EGA&#x000a0;has historically been calculated according to the first day of a patient's LMP instead of a first-trimester ultrasound, which is not always widely available. Due to the limited availability of ultrasound in some regions, the WHO states that 1 ultrasound before 24 weeks is sufficient to assess for fetal abnormalities and confirm dating.<xref ref-type="bibr" rid="article-105819.r36">[36]</xref>&#x000a0;ACOG guidelines recommend that the EDD be determined at the initial visit by LMP in patients with a reliable LMP or early ultrasound; however, in pregnant patients with uncertain dating, including individuals with irregular cycles, an uncertain last menstrual period, or a uterine size-gestational age discrepancy, an early ultrasound, preferably in the first trimester, is indicated to determine a more accurate EDD and exclude a multiple gestation.<xref ref-type="bibr" rid="article-105819.r35">[35]</xref><xref ref-type="bibr" rid="article-105819.r9">[9]</xref>&#x000a0;Other indications for first-trimester ultrasound include&#x000a0;pelvic pain, suspected ectopic pregnancy, vaginal bleeding, suspected trophoblastic disease, nuchal translucency screening, evaluation of pelvic or uterine abnormalities, and chorionic villus sampling guidance.<xref ref-type="bibr" rid="article-105819.r37">[37]</xref><xref ref-type="bibr" rid="article-105819.r38">[38]</xref>&#x000a0;See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/128638">Sonography 1st Trimester Assessment, Protocols, and Interpretation</ext-link>," for more information.&#x000a0;</p>
        <p>When ultrasound imaging, preferably transvaginally, is used, the estimated gestational age should be based on the crown-rump length (CRL) measurement, which is accurate within 5 to 7 days up to 13 6/7 weeks gestation. At 14 0/7 weeks gestation and beyond, a CRL measurement is less accurate, therefore, second-trimester fetal biometry should be used at that point to calculate the fetal EGA. See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/128639">Sonography 2nd Trimester Assessment, Protocols, and Interpretation</ext-link>," for more information. ACOG recommends that 3 separate CRL measurements be obtained and the EDD and EGA be established based on the average CRL measurement. The measurement technique should use a straight line from the fetal cranium to the caudal rump in a midsagittal plane, with a view of the genital tubercle and a longitudinal fetal spine.&#x000a0;A gestational sac diameter is not reliable for EDD calculation and is not recommended.<xref ref-type="bibr" rid="article-105819.r35">[35]</xref>&#x000a0;Moreover, the accuracy of ultrasound dating varies from 4 to 7 days in the first trimester, 10 to 14 days in the second trimester, and 21 days in the third trimester.<xref ref-type="bibr" rid="article-105819.r9">[9]</xref>&#x000a0;Therefore, if the calculated ultrasound EGA before 14 0/7 weeks gestation differs &#x0003e;7 days from the EGA calculated by the LMP, the final EDD should be changed to the dating determined by ultrasound. Additionally, pregnancies with an EDD unconfirmed by an ultrasound examination before 22 0/7 weeks gestational age are considered suboptimally dated, according to ACOG.<xref ref-type="bibr" rid="article-105819.r35">[35]</xref>&#x000a0;</p>
        <p>
<bold>High-Risk Pregnancies</bold>
</p>
        <p>Pregnancies with conditions that increase the risk of antepartum fetal demise are classified as high-risk; in these patients, increased surveillance is indicated.<xref ref-type="bibr" rid="article-105819.r39">[39]</xref>&#x000a0;Conditions that determine a pregnancy is high-risk are not well-defined; however, obstetrical history or maternal, fetal, and placental factors can indicate an increased risk of stillbirth, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fetal indications
<list list-type="bullet"><list-item><p>Fetal growth restriction</p></list-item><list-item><p>Multiple gestation</p></list-item><list-item><p>Fetal anomalies or aneuploidy</p></list-item><list-item><p>Decreased fetal movement</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Maternal indications
<list list-type="bullet"><list-item><p>Diabetes (gestational or preexisting)</p></list-item><list-item><p>Systemic lupus erythematous</p></list-item><list-item><p>Thyroid disorders</p></list-item><list-item><p>Sickle cell disease</p></list-item><list-item><p>Renal or liver disease</p></list-item><list-item><p>Substance abuse</p></list-item><list-item><p>Hypertensive disorders</p></list-item><list-item><p>Maternal age older than 35 years</p></list-item><list-item><p>Obesity</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Obstetrical indications
<list list-type="bullet"><list-item><p>History of preterm delivery, fetal demise, preeclampsia</p></list-item><list-item><p>Placental abruption</p></list-item><list-item><p>Postterm pregnancy</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Placental indications
<list list-type="bullet"><list-item><p>Vasa previa</p></list-item><list-item><p>Single umbilical cord</p></list-item><list-item><p>Polyhydramnios&#x000a0;<xref ref-type="bibr" rid="article-105819.r39">[39]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Maternal-fetal medicine specialists should be consulted in high-risk pregnancies to help determine the best management course for a patient, including the timing and mode of delivery. Additionally, antepartum fetal surveillance, ultrasounds for fetal growth assessment, and optimization of underlying comorbid conditions are some strategies used to help mitigate adverse outcome risks in these patients.<xref ref-type="bibr" rid="article-105819.r40">[40]</xref></p>
        <p>
<bold>Antepartum Care in the Second and Third Trimester</bold>
</p>
        <p>Following the initial prenatal visit, pregnant patients typically are scheduled to see a clinician every 4 weeks in the second trimester (ie, from 14 to 28 weeks gestation) and more frequently in the third trimester (ie, from 28 weeks to delivery), increasing to every 2 weeks from 28 to 36 weeks gestation, then every week from 36 weeks until birth.<xref ref-type="bibr" rid="article-105819.r41">[41]</xref>&#x000a0;The frequency of visits and recommended monitoring increases as pregnancy progresses due to the increased risk of complications and onset of labor as the EDD approaches. Moreover, subsequent antepartum care in the second and third trimesters comprises ongoing assessments, supportive patient education with shared decision-making, and&#x000a0;interventions that frequently involve various interprofessional team members. As delivery approaches, the antepartum care in these trimesters is characterized by continued discussions and preparation regarding labor and postpartum issues and delivery expectations.&#x000a0;See StatPearls' companion reference, "Antepartum Care in the Second and Third Trimester," for more information.</p>
      </sec>
      <sec id="article-105819.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Antepartum Anticipatory Counseling</bold>
</p>
        <p>Patient education and anticipatory counseling are essential components of antepartum care and often comprise a significant portion of each prenatal visit. Appropriate counseling can decrease patient anxiety, create a supportive maternal experience, and reduce adverse outcomes. Therefore, clinicians should thoroughly address general issues (eg, appropriate weight gain, nutrition, and physical activity) as well as individualized concerns that may arise.<xref ref-type="bibr" rid="article-105819.r42">[42]</xref></p>
        <p>
<bold>Weight gain</bold>
</p>
        <p>Clinicians should initiate discussions regarding weight gain during pregnancy with patients at the first prenatal visit and provide recommendations based on prepregnancy BMI and individual risk factors. Furthermore, continued monitoring of a patient's weight gain is an essential part of antepartum care, as both inadequate and excessive weight gain are associated with pregnancy complications. Poor maternal weight gain is associated with feeding difficulties and low infant birth weight; maternal obesity increases the risk of fetal macrosomia, gestational diabetes, gestational hypertension, preeclampsia, and cesarean section.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref>&#x000a0;Furthermore, excessive weight gain has been associated with other adverse outcomes, including low 5-minute Apgar scores, seizures, hypoglycemia, and meconium aspiration syndrome, as well as chronic conditions (eg, childhood obesity, hypertension, and diabetes).<xref ref-type="bibr" rid="article-105819.r43">[43]</xref>&#x000a0;Obese pregnant women also have an increased risk of antepartum cardiac dysfunction, proteinuria, nonalcoholic fatty liver disease, and sleep apnea, as well as intrapartum complications, including endometritis, labor induction failure, venous thrombosis, and wound dehiscence. Macrosomia, which has a higher incidence in obese patients, is also associated with maternal complications (eg, protracted or arrest of labor, uterine rupture, genital tract lacerations, and postpartum hemorrhage). Additionally, macrosomic neonates have an increased&#x000a0;risk of shoulder dystocia, clavicular fractures,&#x000a0;brachial plexus injuries, and nerve palsies. A recent meta-analysis showed the highest risk of adverse outcomes occurred in women with a BMI of &#x0003e;40 and a high total gestational weight gain.<xref ref-type="bibr" rid="article-105819.r44">[44]</xref>&#x000a0;The same meta-analysis recommended the following range for gestational weight gain for each prepregnancy weight class:</p>
        <list list-type="bullet">
          <list-item>
            <p>Underweight&#x000a0;(BMI &#x0003c;18.5): 14 to &#x0003c;16 kg</p>
          </list-item>
          <list-item>
            <p>Normal weight (BMI 18.5&#x000a0;to 24.9): 10 to &#x0003c;18 kg</p>
          </list-item>
          <list-item>
            <p>Overweight (BMI 25 to 29.9): 2 to &#x0003c;16 kg</p>
          </list-item>
          <list-item>
            <p>Obesity grade 1 (BMI 30 to 34.9): 2 to &#x0003c;6 kg</p>
          </list-item>
          <list-item>
            <p>Obesity grade 2 (BMI 35 to 39.9): weight loss or gain of 0 to &#x0003c;4 kg</p>
          </list-item>
          <list-item>
            <p>Obesity grade 3 (BMI &#x02265;40): 0 to &#x0003c;6 kg&#x000a0;<xref ref-type="bibr" rid="article-105819.r44">[44]</xref></p>
          </list-item>
        </list>
        <p>These gestational weight gain ranges for pregnant patients with obesity grades 1, 2, or 3 were lower than those recommended by the US National Academy of Medicine guidelines, which recommend 5 to 9 kg in this population.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref>&#x000a0;Obese patients are more prevalent than underweight patients and continue to increase, with a reported prevalence in the US of approximately 34%.<xref ref-type="bibr" rid="article-105819.r45">[45]</xref> Antepartum weight loss is not recommended due to an associated risk of small for gestational age infants. Therefore, in obese pregnant women, the primary management involves diet and behavioral modifications and increased exercise.<xref ref-type="bibr" rid="article-105819.r45">[45]</xref> However, several studies have suggested that a patient's prepregnancy BMI has a more significant effect on adverse outcomes than the total gestational weight gain.<xref ref-type="bibr" rid="article-105819.r44">[44]</xref>&#x000a0;Clinicians performing preconceptual counseling should encourage patients to have a normal BMI before becoming pregnant. For obese patients, the most effective intervention is weight loss before conception.<xref ref-type="bibr" rid="article-105819.r45">[45]</xref> See StatPearls' companion reference,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/27609">Preconception Counseling</ext-link>," for additional information.&#x000a0;</p>
        <p>
<bold>Dietary recommendations</bold>
</p>
        <p>In addition to general weight gain, adequate nutritional intake and avoidance of harmful dietary products are essential for a healthy pregnancy. Adequate consumption of calories and nutrients is not only critical for fetal development and maternal physiologic demand but also for the prevention of pregnancy complications and long-term adverse outcomes. Approximately 350 to 450 additional calories above the patient's average daily intake is recommended during pregnancy. Because most women have a diet with inadequate amounts of micronutrients, routine supplementation, and a healthy, balanced diet are recommended. Prenatal vitamins are recommended in all pregnant women to help achieve the recommended amount of micronutrients during pregnancy, including&#x000a0;vitamin D, folic acid, iron, calcium, and omega-3 fatty acids (see <bold>Table</bold>. Recommended Micronutrients in Pregnancy).<xref ref-type="bibr" rid="article-105819.r42">[62]</xref><xref ref-type="bibr" rid="article-105819.r46">[46]</xref><xref ref-type="bibr" rid="article-105819.r42">[42]</xref>&#x000a0;However, patients should be counseled on the recommended amount of micronutrients as many prenatal vitamins do not contain the daily amount of recommended micronutrients, and ingestion of several micronutrient sources may lead to overdoses.<xref ref-type="bibr" rid="article-105819.r47">[47]</xref></p>
        <table-wrap id="article-105819.table1" position="float" orientation="portrait">
          <caption>
            <title>Table. Recommended Micronutrients in Pregnancy</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">
<bold>Micronutrient</bold>
</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">
<bold>Recommended Daily Intake</bold>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="width: 335px; height: 35px;" rowspan="1" colspan="1">
<p>Carbohydrates</p>
</td>
                <td style="width: 363.906px; height: 35px;" rowspan="1" colspan="1">175 g/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Protein</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">71 g/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Omega-3 fatty acids</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">1.4 g/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Vitamin A</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">770 &#x003bc;g retinol activity equivalents/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Vitamin C</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">85 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Vitamin D</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">600 IU/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Vitamin E&#x000a0;</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">15 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Vitamin K</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">90 &#x003bc;g/day</td>
              </tr>
              <tr style="height: 16px;">
                <td style="width: 335px; height: 16px;" rowspan="1" colspan="1">Vitamin B<sub>6</sub>&#x000a0;</td>
                <td style="width: 363.906px; height: 16px;" rowspan="1" colspan="1">1.9 mg/day</td>
              </tr>
              <tr style="height: 16px;">
                <td style="width: 335px; height: 16px;" rowspan="1" colspan="1">Vitamin B<sub>12</sub></td>
                <td style="width: 363.906px; height: 16px;" rowspan="1" colspan="1">2.6 &#x003bc;g/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Choline</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">450 mg/day</td>
              </tr>
              <tr style="height: 13.5312px;">
                <td style="width: 335px; height: 13.5312px;" rowspan="1" colspan="1">Chromium</td>
                <td style="width: 363.906px; height: 13.5312px;" rowspan="1" colspan="1">30&#x000a0;&#x003bc;g/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Copper</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">1 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Magnesium</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">400 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Manganese</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">2 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Folate</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">600 &#x003bc;g/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Calcium</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">1000 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Iodine</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">220 &#x003bc;g/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Iron</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">27 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Zinc</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">11 mg/day</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 335px; height: 13px;" rowspan="1" colspan="1">Selenium</td>
                <td style="width: 363.906px; height: 13px;" rowspan="1" colspan="1">70&#x000a0;&#x003bc;g/day</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Increased amounts of these micronutrients are necessary to support fetal growth and development and replace subsequent maternal deficiencies secondary to gestational demands. For instance, iron deficiency resulting in first-trimester anemia is associated with preterm delivery and low birth weight, and choline&#x000a0;supplementation may improve fetal neurodevelopment, particularly in women with a history of alcohol abuse. Moreover, several studies have demonstrated that certain micronutrients may help prevent preeclampsia.<xref ref-type="bibr" rid="article-105819.r48">[48]</xref>&#x000a0;Therefore, clinicians should encourage patients to consume foods that contain these essential nutrients, including fortified cereals, pasta, legumes, bread, cheese, yogurt, salmon, and eggs, ideally before conception.<xref ref-type="bibr" rid="article-105819.r42">[42]</xref>&#x000a0;Folic acid supplementation of 400 &#x003bc;g daily is recommended in all pregnant women to prevent neural tube defects; in patients with a high risk for neural tube defects, including those with a family history of neural tube defects, taking&#x000a0;antiepileptic drugs, with pregestational diabetes, or with obesity,&#x000a0;the optimal dosage for folic acid supplementation is less defined, ranging from 1,000 to&#x000a0;4,000 &#x003bc;g daily.<xref ref-type="bibr" rid="article-105819.r49">[49]</xref>&#x000a0;In patients with anemia, additional iron supplementation may be prescribed empirically. Several daily oral iron supplements are available, including ferrous sulfate and ferrous gluconate. Intravenous formulations may be used in select patients (eg, intolerant of oral therapy or severe anemia).<xref ref-type="bibr" rid="article-105819.r31">[31]</xref>&#x000a0;Vegetarian and vegan pregnant patients should be advised to supplement nutrients (eg, vitamins B<sub>12</sub>&#x000a0;and D) primarily found in animal products.<xref ref-type="bibr" rid="article-105819.r50">[50]</xref>&#x000a0;Clinicians should also advise patients not to follow any weight-loss diet or fad diet that restricts the consumption of critical nutrients during pregnancy.<xref ref-type="bibr" rid="article-105819.r48">[48]</xref></p>
        <p>Foods that should be avoided or restricted in pregnancy include soft cheeses made from unpasteurized milk, deli meats, sprouts, melons not eaten immediately after cutting, and raw or smoked fish due to potential&#x000a0;<italic toggle="yes">Listeria monocytogenes&#x000a0;</italic>contamination. The CDC recommends avoiding all unpasteurized foods during pregnancy to prevent listeriosis.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref>&#x000a0;Additionally, fish with a high mercury content (eg, swordfish, shark, orange roughy) and all raw fish should be avoided. ACOG recommends that pregnant patients limit most seafood to 2 or 3 servings a week and consumption of some fish (eg, albacore tuna and Chilean sea bass) to 6 oz a week.<xref ref-type="bibr" rid="article-105819.r51">[51]</xref>&#x000a0;Drinks containing caffeine or artificial sweeteners should be limited during pregnancy. Ingestion of &#x0003e;350 mg of caffeine daily (ie, 3.5 cups of coffee) is associated with early pregnancy loss, preterm delivery, and low birth weight; therefore, caffeine should be limited to&#x000a0;200 mg per day&#x000a0;during pregnancy. Furthermore, artificial sweeteners have been associated with large for gestational age infants, childhood obesity, and an&#x000a0;increased risk of metabolic syndrome later in life.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref>&#x000a0;Also, foods containing simple sugars, processed foods, and trans and saturated fats should be limited during pregnancy.<xref ref-type="bibr" rid="article-105819.r48">[48]</xref></p>
        <p>
<bold>Smoking, alcohol, and illicit drug use&#x000a0;</bold>
</p>
        <p>Although the overall prevalence of cigarette smoking during pregnancy has decreased significantly throughout the US, 7.2% of pregnant women continue to smoke cigarettes. Tobacco use during pregnancy is associated with miscarriage, congenital anomalies, fetal demise, fetal growth restriction, preterm birth, placental abruption, sudden infant death syndrome, and pulmonary dysfunction. Therefore, identifying patients during the course of antepartum care is essential to prevent adverse outcomes. counsel patients extensively regarding risk factors associated with cigarette use during pregnancy, and implement a quitting plan with the identification of foreseeable roadblocks and obstacles to doing so. Behavioral therapy is the preferred method to facilitate tobacco cessation in pregnant patients. Due to the lack of evidence supporting pharmacotherapy or nicotine replacement to assist with cessation attempts during pregnancy, the USPTF stated that the effectiveness in pregnant patients could not be determined.<xref ref-type="bibr" rid="article-105819.r52">[52]</xref></p>
        <p>Like tobacco, alcohol use during pregnancy is associated with adverse effects, including neurological impairment and fetal alcohol spectrum disorder. Fetal alcohol spectrum disorder comprises several abnormalities and functional impairments with varying severity, including growth restriction, notable dysmorphic facial features (eg, short palpebral fissures, smooth philtrum, and thinned vermilion border), and other cardiac, skeletal, renal, auditory, and ophthalmologic dysfunctions. In the US, fetal alcohol spectrum disorder has a reported incidence of&#x000a0;1.1% to 5% but is underdiagnosed.<xref ref-type="bibr" rid="article-105819.r53">[53]</xref> While the exact dose-effect correlation between alcohol use in pregnancy and fetal defects is unknown, several studies show an increased risk among those exposed to excessive binge-drinking behavior.&#x000a0;Fetal alcohol spectrum disorder is a well-known complication of excessive fetal alcohol exposure, which is most frequently reported in infants of individuals who ingest &#x0003e;6 drinks a day. However, adverse effects (eg, reduced femur length, decreased birth weight, and colic) have also been reported in women with minimal amounts of alcohol use during pregnancy.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref>&#x000a0;Therefore, clinicians should advise patients to completely abstain from alcohol use during pregnancy to prevent alcohol's teratogenic effects.&#x000a0;</p>
        <p>Illicit drug use, including prescription opioids during pregnancy, is also of significant concern to both maternal and fetal outcomes. Up to 40% of pregnant women report having used an addictive drug. Adverse effects of substance abuse include teratogenic effects, neonatal abstinence syndrome, developmental impairment, and comorbid conditions such as depression, anxiety, and infectious diseases. Therefore, ACOG recommends universal screening in pregnant patients to decrease the risk of a missed diagnosis.<xref ref-type="bibr" rid="article-105819.r54">[54]</xref>&#x000a0;Though marijuana is legal in several states, patients should be advised against use during pregnancy due to increased risks that have been found, including low birth weight and preterm labor.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref>&#x000a0;Management of pregnant patients with substance abuse disorders is multifocal, including referral to addiction specialists and rehabilitation programs, infectious disease testing, mental health screening, ultrasound assessment, and antenatal fetal surveillance.<xref ref-type="bibr" rid="article-105819.r55">[55]</xref></p>
        <p>
<bold>Physical activity</bold>
</p>
        <p>Exercise during pregnancy has several benefits, including decreasing the risk&#x000a0;of gestational diabetes, hypertensive disorders, operative deliveries, excessive gestational and postpartum weight gain, and postpartum depression.<xref ref-type="bibr" rid="article-105819.r56">[56]</xref>&#x000a0;Patients may have specific concerns regarding exercise safety during pregnancy with an emphasis on promoting healthy lifestyles during antepartum care. ACOG recommends that after thorough clinical evaluation and with no contraindications, pregnant women should be encouraged to participate in regular, moderate-intensity physical activity in sessions of 30 to 45 minutes daily for approximately 150 minutes each week, depending on their starting fitness level. In sedentary patients, physical activity levels should begin with low-intensity exercise and increase gradually.<xref ref-type="bibr" rid="article-105819.r56">[56]</xref> Clinicians should advise patients to gauge exercise intensity by perceived exertion instead of heart rate, which&#x000a0;may be affected by pregnancy. Furthermore, patients should be instructed to accommodate exercise for pregnancy by avoiding the supine position&#x000a0;since this will put pressure on the vena cava and compromise blood return to the heart, potentially compromising the blood flow to the fetus. Patients should avoid overexertion and dehydration by exercising in a temperature-controlled environment, wearing loose clothing, and remaining well-hydrated.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref></p>
        <p>Exercise activities considered safe in pregnancy include walking, stationary cycling, aerobic dancing, resistance exercises, stretching, swimming, and water aerobics. However, clinicians should counsel patients to be aware of warning signs or symptoms of a potential problem. These warning signs include regular painful contractions, vaginal bleeding, dyspnea on exertion, dizziness, headache, chest pain, or calf pain. If these symptoms should occur, the pregnant patient should stop exercising and consult with her clinician immediately.<xref ref-type="bibr" rid="article-105819.r56">[56]</xref><xref ref-type="bibr" rid="article-105819.r43">[43]</xref></p>
        <p>Relative contraindications to exercise during pregnancy include heavy smoking, poorly controlled disorders (eg, seizure disorder, hyperthyroidism, type 1 diabetes, or hypertension), morbid obesity, malnutrition, intrauterine growth restriction, chronic bronchitis, unevaluated maternal cardiac arrhythmia, history of a severely sedentary lifestyle, symptomatic or severe anemia, and heavy smoking.&#x000a0;Absolute contraindications include incompetent cervix or cerclage, multifetal gestations with an increased risk of preterm delivery, persistent vaginal bleeding, preterm labor, placenta previa present after 26 weeks gestation, rupture of membranes, preeclampsia or pregnancy-induced hypertension, significant heart disease, or restrictive lung disease. Activities in which the risk of trauma to the abdomen or falls is increased should be avoided (e.g., skydiving, scuba diving, contact sports, horseback riding, hot yoga, and gymnastics).&#x000a0;Heavy weightlifting and long-distance running are also discouraged due to overexertion and dehydration risks.<xref ref-type="bibr" rid="article-105819.r43">[43]</xref></p>
        <p>
<bold>Travel</bold>
</p>
        <p>ACOG states that pregnant women may safely travel until 36 weeks of gestation, provided there are no complications; however, patients should be advised that when obstetric emergencies occur during travel, they most commonly happen in the first and third trimesters. Modern, adequately pressurized aircraft pose no harm to pregnant patients or fetuses. Patients are advised to ambulate every hour on long flights to prevent thromboembolism and to wear seat belts throughout the flight. Seat belt safety regarding automobile travel should be discussed with all pregnant patients during antepartum care. Specifically, in 3-point restraint seatbelts, the shoulder portion of the strap should be firmly positioned between the breasts, and the lap belt should be safely positioned under the abdomen and across the upper portion of the thigh. Both should be positioned across the body tightly, and airbags should always be present in vehicles and utilized in the event of a high-impact accident.<xref ref-type="bibr" rid="article-105819.r57">[57]</xref><xref ref-type="bibr" rid="article-105819.r58">[58]</xref><xref ref-type="bibr" rid="article-105819.r59">[59]</xref></p>
      </sec>
      <sec id="article-105819.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Antepartum care is the health care provided during pregnancy to optimize outcomes for both the mother and the fetus. The primary objectives are to identify high-risk pregnancies and to monitor the health of the mother and the development of the fetus. Prenatal visits are an intricate balance of maternal and fetal management aimed to prevent significant maternal and fetal morbidity and mortality and provide support throughout the prenatal course. Close follow-up with timely review of new complaints or issues, physical exam findings, sonography abnormalities, and laboratory results facilitate the necessary interventions. These may include escalation of care to more frequent antepartum care visits, close follow-up by maternal-fetal medicine specialists, antepartum fetal surveillance, and potential early delivery depending on the gestational age, clinical picture, and potential improvement of outcomes.</p>
        <p>While many interventions can be performed with relative ease, multiple obstacles may prevent the implementation of these recommendations. Clinicians may have racial biases, insufficient knowledge of updated guidelines, or miss diagnoses that lead to suboptimal care. Furthermore, social determinants of health may frequently prevent patient compliance with visits or management recommendations, including reduced access to prenatal facilities, unreliable transportation, communication barriers, childcare needs, and medication costs, resulting in poor patient outcomes. Because of this, clinicians should strive to remain current on all obstetric guidelines, provide supportive, unbiased care, and identify any barriers to antepartum interventions to optimize maternal-fetal outcomes.<xref ref-type="bibr" rid="article-105819.r2">[2]</xref><xref ref-type="bibr" rid="article-105819.r3">[3]</xref><xref ref-type="bibr" rid="article-105819.r4">[4]</xref></p>
      </sec>
      <sec id="article-105819.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>During the antepartum period, obstetric management involves significant challenges due to the complexity of caring for both the patient and the fetus. The dual focus on maternal and fetal well-being necessitates a team-directed approach involving an interprofessional team to enhance patient-centered care, outcomes, patient safety, and team performance. In high-risk pregnancies increased surveillance and consultation with maternal-fetal medicine specialists are critical to managing risks and planning delivery. Antepartum care during the second and third trimesters involves ongoing assessments, supportive patient education with shared decision-making, and coordinated interventions from various interprofessional team members. These professionals conduct regular check-ups, laboratory studies, imaging, and antenatal fetal surveillance to monitor maternal and fetal health, addressing concerns such as fetal movement, maternal blood pressure, and weight gain.</p>
        <p>Interprofessional communication is vital, ensuring seamless care coordination and timely response to pregnancy complications, involving collaboration between physicians, nurses, advanced practitioners, nutritionists, and pharmacists to monitor and adjust treatments. High-risk patients may require additional imaging and surveillance, with findings communicated promptly among the team to adjust care plans. Pharmacists play a crucial role in advising on medication safety during pregnancy, while nurses provide patient education and support, reinforcing the care plan and addressing patient concerns. Advanced practitioners often bridge gaps, offering specialized care and guidance on complex cases.&#x000a0;By integrating the expertise of all team members and maintaining open lines of communication, clinicians can effectively manage the challenges of antepartum care, ensuring the safety and well-being of both mother and child throughout the pregnancy.</p>
      </sec>
      <sec id="article-105819.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=105819&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=105819">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/105819/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=105819">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-105819.s8">
        <title>References</title>
        <ref id="article-105819.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peahl</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Novara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Heisler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Moniz</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Patient Preferences for Prenatal and Postpartum Care Delivery: A Survey of Postpartum Women.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>1038</fpage>
            <page-range>1038-1046</page-range>
            <pub-id pub-id-type="pmid">32282598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Byerley</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>A systematic overview of the literature regarding group prenatal care for high-risk pregnant women.</article-title>
            <source>BMC Pregnancy Childbirth</source>
            <year>2017</year>
            <month>Sep</month>
            <day>29</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>329</fpage>
            <pub-id pub-id-type="pmid">28962601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rima Jolivet</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Group antenatal care models in low- and middle-income countries: a systematic evidence synthesis.</article-title>
            <source>Reprod Health</source>
            <year>2018</year>
            <month>Mar</month>
            <day>05</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <pub-id pub-id-type="pmid">29506531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gennaro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Melnyk</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>O&#x002bc;Connor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gibeau</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Nadel</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Improving Prenatal Care for Minority Women.</article-title>
            <source>MCN Am J Matern Child Nurs</source>
            <year>2016</year>
            <season>May-Jun</season>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>147</fpage>
            <page-range>147-53</page-range>
            <pub-id pub-id-type="pmid">26854915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simeone</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Reefhuis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Drews-Botsch</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Lash</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Howley</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Howards</surname>
                <given-names>PP</given-names>
              </name>
              <collab>National Birth Defects Prevention Study</collab>
            </person-group>
            <article-title>Delayed entry into prenatal care among women with pre-pregnancy health conditions, National Birth Defects Prevention Study, 1997-2011.</article-title>
            <source>Prev Med</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>164</volume>
            <fpage>107272</fpage>
            <pub-id pub-id-type="pmid">36152821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolf</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Donahue</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sabo</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Barriers to Attendance of Prenatal and Well-Child Visits.</article-title>
            <source>Acad Pediatr</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>955</fpage>
            <page-range>955-960</page-range>
            <pub-id pub-id-type="pmid">33279734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salomon</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Alfirevic</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Da Silva Costa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Deter</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Figueras</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ghi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Glanc</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Papageorghiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sotiriadis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stirnemann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Toi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yeo</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>53</volume>
            <issue>6</issue>
            <fpage>715</fpage>
            <page-range>715-723</page-range>
            <pub-id pub-id-type="pmid">31169958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papageorghiou</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Ohuma</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Cheikh Ismail</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jaffer</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Bertino</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gravett</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Altman</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Purwar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Noble</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Pang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Victora</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Bhutta</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Villar</surname>
                <given-names>J</given-names>
              </name>
              <collab>International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)</collab>
            </person-group>
            <article-title>International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown-rump length in the first trimester of pregnancy.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>641</fpage>
            <page-range>641-8</page-range>
            <pub-id pub-id-type="pmid">25044000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zolotor</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Carlough</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Update on prenatal care.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Feb</month>
            <day>01</day>
            <volume>89</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-208</page-range>
            <pub-id pub-id-type="pmid">24506122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feltner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Berkman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kistler</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Middleton</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Barclay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Higginbotham</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Oct</month>
            <day>23</day>
            <volume>320</volume>
            <issue>16</issue>
            <fpage>1688</fpage>
            <page-range>1688-1701</page-range>
            <pub-id pub-id-type="pmid">30357304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradywood</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leming-Lee</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Watters</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Blackmore</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Implementing screening for social determinants of health using the Core 5 screening tool.</article-title>
            <source>BMJ Open Qual</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">34376389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phelan</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Screening for Social Determinants of Health During Prenatal Care: Why, What, and How.</article-title>
            <source>Obstet Gynecol Clin North Am</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>629</fpage>
            <page-range>629-638</page-range>
            <pub-id pub-id-type="pmid">37500221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Bibbins-Domingo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Kurth</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Phipps</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Apr</month>
            <day>25</day>
            <volume>317</volume>
            <issue>16</issue>
            <fpage>1661</fpage>
            <page-range>1661-1667</page-range>
            <pub-id pub-id-type="pmid">28444286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cabana</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Chelmow</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Coker</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Donahue</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Ja&#x000e9;n</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ogedegbe</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Stevermer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tsevat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2023</year>
            <month>Sep</month>
            <day>19</day>
            <volume>330</volume>
            <issue>11</issue>
            <fpage>1074</fpage>
            <page-range>1074-1082</page-range>
            <pub-id pub-id-type="pmid">37721605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Voerman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Amiano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Beilin</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Bergstr&#x000f6;m</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Charles</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chatzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chevrier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Corpeleijn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Costet</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Crozier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Doyon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eggesb&#x000f8;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fantini</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Farchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forastiere</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Georgiu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Gori</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grote</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hertz-Picciotto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Heude</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hivert</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Hryhorczuk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Inskip</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Karvonen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kenny</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Koletzko</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>K&#x000fc;pers</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Lagstr&#x000f6;m</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Magnus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Majewska</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>M&#x000e4;kel&#x000e4;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manios</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>McAuliffe</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Mehegan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mel&#x000e9;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mommers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morgen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Moschonis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>N&#x000ed; Chaoimh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nohr</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Nybo Andersen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Oken</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Oostvogels</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pac</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papadopoulou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pekkanen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pizzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Polanska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Porta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Richiardi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rifas-Shiman</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Roeleveld</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ronfani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Standl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stigum</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stoltenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thiering</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thijs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Torrent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tough</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Trnovec</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Gelder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Rossem</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>von Berg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vrijheid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vrijkotte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wijga</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zvinchuk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>S&#x000f8;rensen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lawlor</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Gaillard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jaddoe</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts.</article-title>
            <source>BJOG</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>126</volume>
            <issue>8</issue>
            <fpage>984</fpage>
            <page-range>984-995</page-range>
            <pub-id pub-id-type="pmid">30786138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montagnana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trenti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aloe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cervellin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Human chorionic gonadotropin in pregnancy diagnostics.</article-title>
            <source>Clin Chim Acta</source>
            <year>2011</year>
            <month>Aug</month>
            <day>17</day>
            <volume>412</volume>
            <issue>17-18</issue>
            <fpage>1515</fpage>
            <page-range>1515-20</page-range>
            <pub-id pub-id-type="pmid">21635878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>131</volume>
            <issue>3</issue>
            <fpage>e91</fpage>
            <page-range>e91-e103</page-range>
            <pub-id pub-id-type="pmid">29470343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <article-title>Urinary Tract Infections in Pregnant Individuals.</article-title>
            <source>Obstet Gynecol</source>
            <year>2023</year>
            <month>Aug</month>
            <day>01</day>
            <volume>142</volume>
            <issue>2</issue>
            <fpage>435</fpage>
            <page-range>435-445</page-range>
            <pub-id pub-id-type="pmid">37473414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cabana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pbert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2019</year>
            <month>Sep</month>
            <day>24</day>
            <volume>322</volume>
            <issue>12</issue>
            <fpage>1188</fpage>
            <page-range>1188-1194</page-range>
            <pub-id pub-id-type="pmid">31550038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <collab>American Diabetes Association</collab>
            <article-title>2. Classification and Diagnosis of Diabetes: <italic>Standards of Medical Care in Diabetes-2021</italic>.</article-title>
            <source>Diabetes Care</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>Suppl 1</issue>
            <fpage>S15</fpage>
            <page-range>S15-S33</page-range>
            <pub-id pub-id-type="pmid">33298413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Champion</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Jauk</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Biggio</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Sychowski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tita</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Early Gestational Diabetes Screening Based on ACOG Guidelines.</article-title>
            <source>Am J Perinatol</source>
            <year>2024</year>
            <month>May</month>
            <volume>41</volume>
            <issue>S 01</issue>
            <fpage>e641</fpage>
            <page-range>e641-e647</page-range>
            <pub-id pub-id-type="pmid">35973791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harper</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Jauk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Biggio</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Szychowski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tita</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Early gestational diabetes screening in obese women: a&#x000a0;randomized controlled trial.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2020</year>
            <month>May</month>
            <volume>222</volume>
            <issue>5</issue>
            <fpage>495.e1</fpage>
            <page-range>495.e1-495.e8</page-range>
            <pub-id pub-id-type="pmid">31926951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <article-title>Thyroid Disease in Pregnancy: ACOG Practice Bulletin Summary, Number 223.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>135</volume>
            <issue>6</issue>
            <fpage>1496</fpage>
            <page-range>1496-1499</page-range>
            <pub-id pub-id-type="pmid">32443078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <article-title>Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>125</volume>
            <issue>6</issue>
            <fpage>1510</fpage>
            <page-range>1510-1525</page-range>
            <pub-id pub-id-type="pmid">26000539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qiao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Martelli</surname>
                <given-names>CMT</given-names>
              </name>
              <name>
                <surname>Raja</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Sanchez Clemente</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Ara&#x000f9;jo</surname>
                <given-names>TVB</given-names>
              </name>
              <name>
                <surname>Ximenes</surname>
                <given-names>RAA</given-names>
              </name>
              <name>
                <surname>Miranda-Filho</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Ramond</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brickley</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Epidemic preparedness: Prenatal Zika virus screening during the next epidemic.</article-title>
            <source>BMJ Glob Health</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">34117012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>May</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>e108</fpage>
            <page-range>e108-e122</page-range>
            <pub-id pub-id-type="pmid">26938573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists&#x02019; Committee on Practice Bulletins&#x02014;Obstetrics</collab>
            <collab>Committee on Genetics</collab>
            <collab>Society for Maternal-Fetal Medicine</collab>
            <article-title>Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>136</volume>
            <issue>4</issue>
            <fpage>e48</fpage>
            <page-range>e48-e69</page-range>
            <pub-id pub-id-type="pmid">32804883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grohskopf</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Blanton</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Ferdinands</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Broder</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Talbot</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Fry</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2022</year>
            <month>Aug</month>
            <day>26</day>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-28</page-range>
            <pub-id pub-id-type="pmid">36006864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munoz</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Posavad</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Badell</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Bunge</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Mulligan</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Parameswaran</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Olson-Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Brady</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Pasetti</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Defranco</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Shriver</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Suthar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Coler</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Berube</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Piper</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Cardemil</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Neuzil</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Beigi</surname>
                <given-names>RH</given-names>
              </name>
              <collab>DMID 21-0004 Study Group</collab>
            </person-group>
            <article-title>COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.</article-title>
            <source>Vaccine</source>
            <year>2023</year>
            <month>Aug</month>
            <day>14</day>
            <volume>41</volume>
            <issue>36</issue>
            <fpage>5296</fpage>
            <page-range>5296-5303</page-range>
            <pub-id pub-id-type="pmid">37451878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <article-title>ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>131</volume>
            <issue>3</issue>
            <fpage>e82</fpage>
            <page-range>e82-e90</page-range>
            <pub-id pub-id-type="pmid">29470342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <article-title>Anemia in Pregnancy: ACOG Practice Bulletin, Number 233.</article-title>
            <source>Obstet Gynecol</source>
            <year>2021</year>
            <month>Aug</month>
            <day>01</day>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>e55</fpage>
            <page-range>e55-e64</page-range>
            <pub-id pub-id-type="pmid">34293770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <article-title>Screening for Syphilis In Pregnant Women: Recommendation Statement.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Apr</month>
            <day>15</day>
            <volume>99</volume>
            <issue>8</issue>
            <fpage>Online</fpage>
            <pub-id pub-id-type="pmid">30990298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cabana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pbert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2019</year>
            <month>Jun</month>
            <day>18</day>
            <volume>321</volume>
            <issue>23</issue>
            <fpage>2326</fpage>
            <page-range>2326-2336</page-range>
            <pub-id pub-id-type="pmid">31184701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkins</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sams</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis B: Screening, Prevention, Diagnosis, and Treatment.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>99</volume>
            <issue>5</issue>
            <fpage>314</fpage>
            <page-range>314-323</page-range>
            <pub-id pub-id-type="pmid">30811163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <article-title>Committee Opinion No 700: Methods for Estimating the Due Date.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>May</month>
            <volume>129</volume>
            <issue>5</issue>
            <fpage>e150</fpage>
            <page-range>e150-e154</page-range>
            <pub-id pub-id-type="pmid">28426621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r36">
          <label>36</label>
          <element-citation publication-type="book">
            <source>WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience</source>
            <publisher-name>World Health Organization</publisher-name>
            <publisher-loc>Geneva</publisher-loc>
            <year>2016</year>
            <pub-id pub-id-type="pmid">28079998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mei</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Afshar</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Platt</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>First-Trimester Ultrasound.</article-title>
            <source>Obstet Gynecol Clin North Am</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>829</fpage>
            <page-range>829-852</page-range>
            <pub-id pub-id-type="pmid">31677757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <article-title>AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations.</article-title>
            <source>J Ultrasound Med</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>E13</fpage>
            <page-range>E13-E24</page-range>
            <pub-id pub-id-type="pmid">30308091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <article-title>Indications for Outpatient Antenatal Fetal Surveillance: ACOG Committee Opinion, Number 828.</article-title>
            <source>Obstet Gynecol</source>
            <year>2021</year>
            <month>Jun</month>
            <day>01</day>
            <volume>137</volume>
            <issue>6</issue>
            <fpage>e177</fpage>
            <page-range>e177-e197</page-range>
            <pub-id pub-id-type="pmid">34011892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <article-title>Management of Stillbirth: Obstetric Care Consensus No, 10.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>135</volume>
            <issue>3</issue>
            <fpage>e110</fpage>
            <page-range>e110-e132</page-range>
            <pub-id pub-id-type="pmid">32080052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peahl</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>The evolution of prenatal care delivery guidelines in&#x000a0;the United States.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>224</volume>
            <issue>4</issue>
            <fpage>339</fpage>
            <page-range>339-347</page-range>
            <pub-id pub-id-type="pmid">33316276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fast</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy Myths and Practical Tips.</article-title>
            <source>Am Fam Physician</source>
            <year>2020</year>
            <month>Oct</month>
            <day>01</day>
            <volume>102</volume>
            <issue>7</issue>
            <fpage>420</fpage>
            <page-range>420-426</page-range>
            <pub-id pub-id-type="pmid">32996758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kominiarek</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Peaceman</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Gestational weight gain.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>217</volume>
            <issue>6</issue>
            <fpage>642</fpage>
            <page-range>642-651</page-range>
            <pub-id pub-id-type="pmid">28549978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group</collab>
              <name>
                <surname>Voerman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Inskip</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Amiano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Charles</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chatzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Corpeleijn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Crozier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Doyon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eggesb&#x000f8;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fantini</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Farchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forastiere</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Georgiu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gori</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hertz-Picciotto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Heude</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hivert</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Hryhorczuk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>I&#x000f1;iguez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Karvonen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>K&#x000fc;pers</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Lagstr&#x000f6;m</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lawlor</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Magnus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Majewska</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>M&#x000e4;kel&#x000e4;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manios</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mommers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morgen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Moschonis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nohr</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Nybo Andersen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Oken</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pac</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papadopoulou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pekkanen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pizzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Polanska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Porta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Richiardi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rifas-Shiman</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Roeleveld</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ronfani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Standl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stigum</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stoltenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thiering</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thijs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Torrent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trnovec</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>van Gelder</surname>
                <given-names>MMHJ</given-names>
              </name>
              <name>
                <surname>van Rossem</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>von Berg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vrijheid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wijga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zvinchuk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>S&#x000f8;rensen</surname>
                <given-names>TIA</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jaddoe</surname>
                <given-names>VWV</given-names>
              </name>
              <name>
                <surname>Gaillard</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes.</article-title>
            <source>JAMA</source>
            <year>2019</year>
            <month>May</month>
            <day>07</day>
            <volume>321</volume>
            <issue>17</issue>
            <fpage>1702</fpage>
            <page-range>1702-1715</page-range>
            <pub-id pub-id-type="pmid">31063572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <article-title>Obesity in Pregnancy: ACOG Practice Bulletin, Number 230.</article-title>
            <source>Obstet Gynecol</source>
            <year>2021</year>
            <month>Jun</month>
            <day>01</day>
            <volume>137</volume>
            <issue>6</issue>
            <fpage>e128</fpage>
            <page-range>e128-e144</page-range>
            <pub-id pub-id-type="pmid">34011890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adams</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Pollard</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Audhya</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Evidence-Based Recommendations for an Optimal Prenatal Supplement for Women in the U.S., Part Two: Minerals.</article-title>
            <source>Nutrients</source>
            <year>2021</year>
            <month>May</month>
            <day>28</day>
            <volume>13</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">34071548</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cai</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Mccoy</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Commercially Available Prenatal Vitamins Do Not Meet American College of Obstetricians and Gynecologists Nutritional Guidelines.</article-title>
            <source>Am J Perinatol</source>
            <year>2024</year>
            <month>May</month>
            <volume>41</volume>
            <issue>S 01</issue>
            <fpage>e2547</fpage>
            <page-range>e2547-e2554</page-range>
            <pub-id pub-id-type="pmid">37419140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marshall</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Barbour</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Catalano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Christian</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Krebs</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Oken</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Soltani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thornburg</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>The importance of nutrition in pregnancy and lactation: lifelong consequences.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2022</year>
            <month>May</month>
            <volume>226</volume>
            <issue>5</issue>
            <fpage>607</fpage>
            <page-range>607-632</page-range>
            <pub-id pub-id-type="pmid">34968458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petersen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Benedum</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Tinker</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Werler</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.</article-title>
            <source>Birth Defects Res</source>
            <year>2019</year>
            <month>Nov</month>
            <day>15</day>
            <volume>111</volume>
            <issue>19</issue>
            <fpage>1501</fpage>
            <page-range>1501-1512</page-range>
            <pub-id pub-id-type="pmid">31433116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowensohn</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Stadler</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Naze</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Current Concepts of Maternal Nutrition.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>71</volume>
            <issue>7</issue>
            <fpage>413</fpage>
            <page-range>413-26</page-range>
            <pub-id pub-id-type="pmid">27436176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Emmett</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Emond</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Golding</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A review of guidance on fish consumption in pregnancy: is it fit for purpose?</article-title>
            <source>Public Health Nutr</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>11</issue>
            <fpage>2149</fpage>
            <page-range>2149-2159</page-range>
            <pub-id pub-id-type="pmid">29576029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cabana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Donahue</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ogedegbe</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pbert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2021</year>
            <month>Jan</month>
            <day>19</day>
            <volume>325</volume>
            <issue>3</issue>
            <fpage>265</fpage>
            <page-range>265-279</page-range>
            <pub-id pub-id-type="pmid">33464343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wozniak</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Charness</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.</article-title>
            <source>Lancet Neurol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>760</fpage>
            <page-range>760-770</page-range>
            <pub-id pub-id-type="pmid">31160204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Haight</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Terplan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Snead</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schulkin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Obstetrician-gynecologists' practices and attitudes on substance use screening during pregnancy.</article-title>
            <source>J Perinatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>422</fpage>
            <page-range>422-432</page-range>
            <pub-id pub-id-type="pmid">31666646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wouldes</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stasiak</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Evidence for the Effectiveness and Acceptability of e-SBI or e-SBIRT in the Management of Alcohol and Illicit Substance Use in Pregnant and Post-partum Women.</article-title>
            <source>Front Psychiatry</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>634805</fpage>
            <pub-id pub-id-type="pmid">34025470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ribeiro</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Physical exercise in pregnancy: benefits, risks and prescription.</article-title>
            <source>J Perinat Med</source>
            <year>2022</year>
            <month>Jan</month>
            <day>27</day>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-17</page-range>
            <pub-id pub-id-type="pmid">34478617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <article-title>ACOG Committee Opinion No. 746: Air Travel During Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>132</volume>
            <issue>2</issue>
            <fpage>e64</fpage>
            <page-range>e64-e66</page-range>
            <pub-id pub-id-type="pmid">30045212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <article-title>ACOG Committee Opinion No. 443: Air travel during pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>954</fpage>
            <pub-id pub-id-type="pmid">19888065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-105819.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <article-title>ACOG educational bulletin. Obstetric aspects of trauma management. Number 251, September 1998 (replaces Number 151, January 1991, and Number 161, November 1991). American College of Obstetricians and Gynecologists.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-94</page-range>
            <pub-id pub-id-type="pmid">10190681</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
